HOME
ABOUT US
STRATEGY
TEAM
PORTFOLIO
NEWSROOM
CONTACT
More
4BIO Capital leads SparingVision’s €44.5 million financing round
4BIO Capital announces strategic investment from Japanese pharmaceutical company Kyowa Kirin
4BIO Capital leads Redpin Therapeutics’ $15.5 million Series A
4BIO Capital participates in $110M Series B Financing of Orchard Therapeutics